Trump and Big Pharma tussle over drug price proposal with 3 months until election

It’s been a busy week in the world of drug pricing, but not because of any major changes to the industry’s pricing power or legislation. Instead, drugmakers and President Donald Trump exchanged barbs over a group of executive orders and the president's aim to lower prices.